How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/platelet-aggregation-inhibition.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Platelet Aggregation Inhibition — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Aggregation Inhibition (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Platelet Aggregation Inhibition, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Persantine	DIPYRIDAMOLE	Boehringer Ingelheim	Platelet Aggregation Inhibitor [EPC]	Equilibrative nucleoside transporter 1		1961-01-01
Persantin	Persantin	Boehringer Ingelheim		Equilibrative nucleoside transporter 4, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Boehringer Ingelheim · 2 drugs in Platelet Aggregation Inhibition

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Platelet Aggregation Inhibition:

Cite this brief

Drug Landscape (2026). Platelet Aggregation Inhibition — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/platelet-aggregation-inhibition. Accessed 2026-06-10.

Platelet Aggregation Inhibition full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing